EyePoint Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

EyePoint Pharmaceuticals, Inc.

EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release…

Biotechnology
US, Watertown [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

EyePoint Pharmaceuticals, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

EyePoint Pharmaceuticals, Inc. can't present revenue by segment

End of EYPT's Analysis
CIK: 1314102 CUSIP: 30233G209 ISIN: US30233G2093 LEI: - UEI: -
Secondary Listings
EYPT has no secondary listings inside our databases.